Tohda Michihisa, Watanabe Hiroshi
Division of Medicinal Pharmacology, Institute of Natural Medicine, University of Toyama.
Wakan-yaku Theory-Based Integrated Pharmacology, Graduate School of Innovative Life Science, University of Toyama.
Biol Pharm Bull. 2018 Nov 1;41(11):1627-1631. doi: 10.1248/bpb.b18-00427. Epub 2018 Aug 28.
This review article mentions about the following points, and proposes its importance and positive thinking. 1) Wakan-yaku (Japanese oriental medicines) is covered by the national health insurance system in Japan as therapeutic drugs to be actively used in medical practice to treat illness. 2) Applications of Wakan-yaku is accomplished based on the reliable own theories which are established with long histories. 3) Promotion of studies based on these theories will be highly expected to find novel view points which breaks conventional concepts and to novel standards for developing new medicinal drugs. Although studies based on the reliable Wakan-yaku theories are not advancing satisfactorily till now, the possibilities to obtain the advanced resources for drugs and novel viewpoints for experiments by studies about Wakan-yaku theories are discussed in this review.
这篇综述文章提到了以下几点,并提出了其重要性和积极的思考。1)汉方药(日本传统东方药物)在日本被纳入国家医疗保险体系,作为在医疗实践中积极用于治疗疾病的治疗药物。2)汉方药的应用是基于有着悠久历史且可靠的自身理论来完成的。3)基于这些理论的研究有望找到突破传统观念的新观点,并为开发新药提供新的标准。尽管到目前为止基于可靠的汉方药理论的研究进展并不令人满意,但本综述讨论了通过对汉方药理论的研究获得先进药物资源和新实验观点的可能性。